Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.48.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.2SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
MM.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MM.2SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
JN.1.7.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.8SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.2.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.4SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
LB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.3.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.2.3SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.3.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.2SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.2.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.3SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.3.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.2.5SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
LU.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LU.2SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
LF.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.3.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
LB.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.7SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.3.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.6SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.3.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
LB.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.4SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.2.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.15SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1.1.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
LB.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
KP.3.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
XDYSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDYSYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
JN.1.16.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.16.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
LW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used